Готові списки джерел за темами / Diagnostics of diseases

Добірка наукової літератури з теми "Diagnostics of diseases"

Автор: Grafiati
Опубліковано: 30 травня 2022
Оновлено: 31 травня 2022

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Зміст

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Diagnostics of diseases".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Статті в журналах з теми "Diagnostics of diseases"

1

Guseynov, Arif. "MODERN DIAGNOSTICS BREAST DISEASES." Clinical Medicine and Pharmacology 6, no. 1 (June 18, 2020): 6–15. http://dx.doi.org/10.12737/2409-3750-2020-6-1-6-15.

Повний текст джерела
Анотація:
The lecture provides information for medical practitioners on the problems of modern diagnosis of breast pathology. The methods of the research, the advantages and disadvantages of each method are described in detail. The questions of differential diagnosis are presented, the optimal schemes and approaches in the diagnosis of the most common diseases of the mammary gland are described.
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Kessel, M. "Neglected Diseases, Delinquent Diagnostics." Science Translational Medicine 6, no. 226 (March 5, 2014): 226ed6. http://dx.doi.org/10.1126/scitranslmed.3008194.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Schulz-Knappe, Peter, and Petra Budde. "From Diagnostics to Companion Diagnostics: Targeting Autoimmune Diseases." Clinical OMICs 2, no. 12 (December 2015): 26–28. http://dx.doi.org/10.1089/clinomi.02.12.09.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Kostrova, I. V., and O. B. Prikhodko. "DIFFICULTIES OF DIFFERENTIAL DIAGNOSTICS OF INTERSTITIAL LUNGS DISEASES." Amur Medical Journal, no. 3 (2017): 134–35. http://dx.doi.org/10.22448/amj.2017.3.134-135.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Adamczyk, Jakub, Dominik Sieroń, Karolina Sieroń, Aleksander Sieroń, and Ewa Kucharska. "METHODS OF SPECTRAL DIAGNOSTICS IN MODERN PREVENTION OF ONCOLOGICAL DISEASES." Wiadomości Lekarskie 73, no. 7 (2020): 1313–17. http://dx.doi.org/10.36740/wlek202007101.

Повний текст джерела
Анотація:
This paper contains structured information on photodynamic diagnostics. Photodynamic diagnostics is a young diagnostic modality used in the detection of pre-neoplastic and very early neoplastic lesions. A characteristic feature of the presented method is its completely non-invasive nature and thus the possibility of multiple repetitions at the same patient. This is very important in modern health care and in preventive measures. Aim of the paper: The article aims to present technical and diagnostic possibilities of a photodynamic method as one of the possible modalities of screening diagnostics in patients with ambiguous clinical picture of early neoplastic lesions.
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Tang, Yi-Wei, Gary W. Procop, and David H. Persing. "Molecular diagnostics of infectious diseases." Clinical Chemistry 43, no. 11 (November 1, 1997): 2021–38. http://dx.doi.org/10.1093/clinchem/43.11.2021.

Повний текст джерела
Анотація:
Abstract Over the past several years, the development and application of molecular diagnostic techniques has initiated a revolution in the diagnosis and monitoring of infectious diseases. Microbial phenotypic characteristics, such as protein, bacteriophage, and chromatographic profiles, as well as biotyping and susceptibility testing, are used in most routine laboratories for identification and differentiation. Nucleic acid techniques, such as plasmid profiling, various methods for generating restriction fragment length polymorphisms, and the polymerase chain reaction (PCR), are making increasing inroads into clinical laboratories. PCR-based systems to detect the etiologic agents of disease directly from clinical samples, without the need for culture, have been useful in rapid detection of unculturable or fastidious microorganisms. Additionally, sequence analysis of amplified microbial DNA allows for identification and better characterization of the pathogen. Subspecies variation, identified by various techniques, has been shown to be important in the prognosis of certain diseases. Other important advances include the determination of viral load and the direct detection of genes or gene mutations responsible for drug resistance. Increased use of automation and user-friendly software makes these technologies more widely available. In all, the detection of infectious agents at the nucleic acid level represents a true synthesis of clinical chemistry and clinical microbiology techniques.
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Giannobile, William V. "Salivary diagnostics for periodontal diseases." Journal of the American Dental Association 143 (October 2012): 6S—11S. http://dx.doi.org/10.14219/jada.archive.2012.0341.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Dahlén, Gunnar. "Microbiological diagnostics in oral diseases." Acta Odontologica Scandinavica 64, no. 3 (January 2006): 164–68. http://dx.doi.org/10.1080/00016350500520318.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Muldrew, Kenneth L. "Molecular diagnostics of infectious diseases." Current Opinion in Pediatrics 21, no. 1 (February 2009): 102–11. http://dx.doi.org/10.1097/mop.0b013e328320d87e.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Siciliano, Gabriele, Leda Volpi, Selina Piazza, Giulia Ricci, Michelangelo Mancuso, and Luigi Murri. "Functional Diagnostics in Mitochondrial Diseases." Bioscience Reports 27, no. 1-3 (June 13, 2007): 53–67. http://dx.doi.org/10.1007/s10540-007-9037-0.

Повний текст джерела
Анотація:
Mitochondrial diseases (MD) with respiratory chain defects are caused by genetic mutations that determine an impairment of the electron transport chain functioning. Diagnosis often requires a complex approach with measurements of serum lactate, magnetic resonance spectroscopy (MRS), muscle histology and ultrastructure, enzymology, genetic analysis, and exercise testing. The ubiquitous distribution of the mitochondria in the human body explains the multiple organ involvement. Exercise intolerance is a common symptom of MD, due to increased dependence of skeletal muscle on anaerobic metabolism, with an excess lactate generation, phosphocreatine depletion, enhanced free radical production, reduced oxygen extraction and electron flux through the respiratory chain. MD treatment has included antioxidants (vitamin E, alpha lipoic acid), coenzyme Q10, riboflavin, creatine monohydrate, dichloroacetate and exercise training. Exercise is a particularly important tool in diagnosis as well as in the management of these diseases.
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Дисертації з теми "Diagnostics of diseases"

1

Nygren, Malin. "Molecular diagnostics of infectious diseases." Doctoral thesis, KTH, Biotechnology, 2000. http://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-2906.

Повний текст джерела
Анотація:

In DNA-based diagnostics, the polymerase chain reaction(PCR) is the most widely used DNA amplification method. Toenable both sensitive and specific detection of agents causinginfectious diseases, the PCR needs to becombined with methodsto prepare the clinical sample containing the genetic materialof the pathogen. Furthermore, methods for detection and DNAsequence analysis of the PCR amplification products are needed.This thesis describes the development of integrated systems fordetection, quantification and characterization ofmicroorganisms.

An immunomagnetic separation (IMS) technique has been usedto isolateBordetella pertussisfrom nasopharyngeal aspiratesamples. The post-PCR detection and typing ofBordetellaspp. was performed by a combination ofrestriction enzyme analysis of the amplified pertussis toxin(PT) promoter region and a solid-phase colorimetric detectionsystem; detection of immobilized amplified nucleic acid(DIANA). To investigate whether this approach could be used forreliable discrimination between the threeBordetellaspp. infecting humans, the PT promoter regionused for diagnostics was sequenced in 33 strains. To determinethe DNA sequence of this polymorphic and repetitive region, anew technique, bidirectional pyrosequencing, was utilized. Thisprocedure was used to resolve the sequence of this DNA region,which is able to form stable secondary structures inconventional Sanger DNA sequencing. A quantitative assay usingcompetitive PCR and the DIANA detection technique was alsodeveloped, for quantification ofB. pertussisin clinical samples.

By arbitrary PCR, a DNA sequence apparently specific forVibrio choleraeO139 Bengal was isolated andcharacterized. A nested PCR assay was developed for sensitiveand specific detection ofV. choleraeO139 Bengal in clinical samples and inenvironmental water samples, where differentiation betweenV. choleraeO139 Bengal andV. choleraO1 is of epidemiological interest.

The magnetic separation approach was also used to capturehuman immunodeficiency virus (HIV-1) RNA from patient plasma. Anested reverse transcription (RT)-PCR with four internalcompetitors was combined with electrophoretic separation andquantification of the PCR amplicons on an automated DNAsequencer. From the internal calibration curve, the amount ofHIV-1 RNA in the sample could be determined. Furthermore, aprimer extension assay was combined with detection andquantification of the competitive PCR products by the samebiochemiluminescent detection technique that is used inpyrosequencing. Quantification of HIV-1 viral load hasimplications in monitoring of antiretroviral therapy and inassessment of disease progression into AIDS.

Key words:bioluminescence,Bordetella, competitive PCR, DNA sequencing, humanimmunodeficiency virus type 1, PCR, pyrosequencing, solid-phasetechnology,Vibrio cholerae

© Malin Nygren, 2000

Стилі APA, Harvard, Vancouver, ISO та ін.
2

Jönsson, Björn. "On leg ischaemia : aspects on epidemiology and diagnostics /." Linköping : Univ, 2005. http://www.bibl.liu.se/liupubl/disp/disp2005/med884s.pdf.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

McCoy, G. F. "The role of vibration emission in the diagnosis of internal diseases of the knee." Thesis, Queen's University Belfast, 1985. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.233274.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Tricou, Vianney M. "Dengue diagnostics and therapeutic interventions in Viet Nam." Thesis, University of Oxford, 2011. http://ora.ox.ac.uk/objects/uuid:46dfff8c-f7d2-4c43-b053-a5438531290a.

Повний текст джерела
Анотація:
Dengue is a major public health problem that affects tens of millions of people annually in tropical and sub-tropical countries. This acute viral infection happens to be severe and even life threatening but there is still no available drug or vaccine. Previous studies have noted early higher viral burden in patients who develop more severe symptoms suggesting that administration of a potent and safe antiviral may prevent progression to severe dengue. To verify this hypothesis, we have conducted the first RCT directed towards reducing the viral burden in vivo by administrating chloroquine (CQ), a cheap and well-tolerated drug that inhibits DENV in vitro with concentrations achievable in vivo, to 307 Vietnamese adults with suspected dengue (257 of them were laboratory-confirmed cases). Unfortunately, we did not see an effect of CQ on the duration of infection. However in patients treated with CQ, we observed a trend towards a lower incidence of severe forms. We did not find any differences in the immune response that can explain this trend. We also found more adverse events, primarily vomiting, with CQ. In addition, we have explored the relationships between clinical features, antibody responses and virological markers in these patients. We found that the early magnitude of viremia is positively associated with disease severity and there are serotype dependent differences in infection kinetics. We found as well that DENV was cleared faster and earlier in patients with secondary infections. To complete this study, we have also evaluated 2 rapid lateral flow tests for the diagnosis of dengue in a panel of plasma samples from 245 RT-PCR confirmed dengue patients and 47 with other febrile illnesses. Our data suggest that the NS1 test component of these tests are highly specific and have similar levels of sensitivity (~60%). Both NS1 assays were significantly more sensitive for primary than secondary dengue. The IgM parameter in the SD Duo test improved overall test sensitivity without compromising specificity. All these findings are of major importance for further anti-viral drug testing.
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Kameda, de Figueiredo Carvalho Koichi. "Testing the Nation : Healthcare policy and innovation in diagnostics for infectious diseases in Brazil." Thesis, Paris, EHESS, 2019. http://www.theses.fr/2019EHES0196.

Повний текст джерела
Анотація:
Le diagnostic in vitro (DIV) est un segment des biotechnologies de santé pour lequel les principaux acteurs se situent dans les pays développés. Parallèlement, le paysage actuel a contraint les compagnies multinationales à transformer leur modèle économique, tout en obligeant les pays non-occidentaux à devenir de nouveaux marchés et des lieux où de nouveaux savoirs et technologies pourraient être produits. Non seulement le Brésil est un marché important en ce qui concerne les produits de santé, mais il possède aussi une longue histoire en matière de fabrication de produits biologiques et pharmaceutiques. Dans ce contexte que les acteurs brésiliens se sont engagés dans production de DIV pour les maladies infectieuses. Ces initiatives articulent la santé publique et les politiques économiques industrielles, soit l’approche qui a été privilégiée dans le cadre du courant néo-développementaliste (neo-desenvolvimentismo) prôné de 2003 à 2016 dans ce pays. Cette thèse a pour objectif d’éclairer le travail des acteurs qui ont organisé la production et l’innovation de DIV dans un monde en mouvement, et dont le positionnement se situe au croisement de questions relevant de la santé publique, de l’autonomie technologique et de l’économie nationale brésilienne. Cette recherche se fonde sur un travail de terrain conduit entre 2014 et 2017, qui inclut des stages dans deux laboratoires rattachés à la fondation Oswaldo Cruz, ainsi que des entretiens avec de nombreux acteurs impliqués dans la production de ces tests diagnostics nationaux
In vitro diagnostics (IVD) is a segment of the health biotechnology industry for which the major players are situated in developed countries. At the same time, the contemporary landscape has compelled multinational companies to transform their business models and non-Western countries to become both new markets and places where new knowledge and technology can be produced. Not only is Brazil an important market for healthcare products, but it also has a long-standing history of producing pharmaceutical and biological innovations. It is in this context that Brazilian actors have engaged in the manufacturing of IVD for infectious diseases. These initiatives articulate public health and industrial economy policies, a preferred approach of the new developmentalism (neo-desenvolvimentismo) that prevailed in the country from 2003 to 2016. This thesis aims to shed light on how these actors organize IVD production and innovation in such a changing world, and at the crossroads of public health, technological autonomy and the national economy in Brazil. The research draws on fieldwork conducted between 2014 and 2017, which involved internships in two biotechnology laboratories linked to the Oswaldo Cruz Foundation, and on interviews with the various actors involved in the initiatives to produce national diagnostic tests
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Näslund, Jonas. "Rift Valley fever : development of diagnostics and vaccines." Doctoral thesis, Umeå universitet, Klinisk mikrobiologi, 2010. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-30676.

Повний текст джерела
Анотація:
Rift Valley Fever virus (RVFV) causes an infection with severe impact on animal and human health. The disease is endemic throughout almost the entire African continent and large regions of the Arabian Peninsula. During epidemics, high mortality is observed in animals, especially among cattle, goats, and sheep. In humans, the symptoms vary from a benign influenza-like disease to a life-threatening hemorrhagic fever. Due to the devastating effect on communities in endemic regions and the possibility of further spread of this virus, there is an imperative need to improve and develop control measurements against this emerging disease. Therefore, this thesis focuses on diagnostics and vaccines against RVFV. RVFV infection kinetics was studied in a mouse model system by detection and quantification of viral genomes, using a developed quantitative real-time PCR (QRT-PCR) method. This novel QRT-PCR method proved to be reliable and serves as a supplement to standard diagnostics, direct virus isolation and serological methods. High levels of viral RNA were found in blood and liver samples from experimentally infected mice during the first days post infection. Thereafter the levels declined rapidly and dropped below detection limit approximately seven days post infection. The QRT-PCR technique was also used in a study aimed to improve diagnosis of RVFV from field samples collected on filter strips. Today, the available RVFV vaccines are only approved for animal use and these vaccines have several shortcomings. Since RVFV is a highly pathogenic organism requiring bio-safety level 3 laboratories, two different none-replicating vaccine approaches have been applied and evaluated using a mouse model. A DNA based vaccine, administered via gene-gun, and the use of virus-like particles (VLP), by the intra-peritoneal route. RVFV specific and neutralising antibodies were raised with both vaccine approaches. However, VLP vaccination against Rift valley Fever proved to be more promising as a future vaccine, since higher titres of neutralising antibodies and improved survival rate were found upon a lethal RVFV challenge in mice. In conclusion, a sensitive and specific method for quantifying RVFV infection and a promising vaccine candidate against RVFV were developed.
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Keršulytė, Gintarė. "Širdies signalų analizės metodų paieška ir kūrimas." Master's thesis, Lithuanian Academic Libraries Network (LABT), 2007. http://vddb.library.lt/obj/LT-eLABa-0001:E.02~2007~D_20070816_142805-77618.

Повний текст джерела
Анотація:
Didelė dalis širdies susirgimų diagnostinių kriterijų gaunama registruojant ir analizuojant kardiosignalus, kurie atspindi tiek elektrinės širdies veiklos sutrikimus (EKG), tiek ir hemodinaminės bei mechaninės veiklos pokyčius, t.y. impedanskardiograma (IKG) ir seismokardiograma (SKG). Dar daugiau, efektyvus širdies susirgimų diagnostikos problemų sprendimas yra naujų kardiosignalų analizės technologijų kūrimas. Jau kelis dešimtmečius Furjė transformacija taikoma EKG dažnumų analizei, tuo tarpu kai IKG ir SKG dažnio charakteristikų vertinimui šis metodas nebuvo naudojamas. Darbo tikslas buvo pritaikyti Furjė analizę įvertinant bei palyginant tris sinchroniškai užregistruotus kardiosignalus, nes jie atspindi elektrinės širdies, hemodinaminės bei mechaninės širdies veiklos pokyčius geriau nei vienas EKG signalas. Kitas darbo tikslas buvo pritaikyti Furjė analizę įvertinant bei palyginant trijų sinchroniškai užregistruotų signalų - EKG, IKG ir SKG dažnio charakteristikas ir koherenciją bei klasifikuoti dvi grupes - "sveikas" ir "ligonis". Rezultatai rodo, kad koherencijos vertinimas ir spektrinė analizė gali būti naudinga gali būti naudingas širdies kraujagyslių bei plaučių sistemų ligų diagnostikai.
A big part of heart disease diagnostics criteria is collected by registration and analysis of cardio signals that reflect the disturbances of the electric heart activity – electrocardiogram (EСG), changes of hemodynamic - impedance cardiograms (IСG) and mechanic activity - seismocardiogram (SСG). ECG analysis is generally applying in clinic practice, but usually in visual way only. Due to the development of the technologies, the bigger amount of data could be stored and more exact analysis of information could be carried out. Therefore, a solution of problem of effective diagnostics of heart diseases is the creation of new technologies for analysis of cardio signals. Previously Fourier series were applied to frequency analysis of ECG, but this method was not applied for estimation of ICG and SCG frequency characteristics. In this thesis the frequency analysis method was applied to three cardio signals, because they reflect the electrical and mechanical work of the human heart better as entirely ECG signal. The main aim of this work was to adapt Fourier transformation to assessing and comparing some characteristics of hereinbefore signals, such as coherence and classify two searching groups - “healthy” and “sick”. Results showed that rating of coherence and spectral analysis could be useful for rightly analyzing and classifying the searching groups.
Стилі APA, Harvard, Vancouver, ISO та ін.
8

López, Siles Mireia. "Ecophysiology and philogeny of Faecalibacterium prausnitzii in healthy and diseased gut. Application in Inflamatory Bowel Disease diagnostics." Doctoral thesis, Universitat de Girona, 2016. http://hdl.handle.net/10803/369044.

Повний текст джерела
Анотація:
In this PhD thesis Faecalibacterium prausnitzii populations of patients with gut disease and healthy individuals have been characterized. First, isolates from healthy volunteers have been phenotypically characterised, which has allowed to gain insight into the physiology of this species. A possible link between F. prausnitzii sensitivity to changes in gut physicochemical conditions and its disappearance in a diseased gut has been revealed. Second, molecular studies on F. prausnitzii populations have allowed to define two phylogroups within this species, and to describe the diversity of phylotypes in healthy individuals and in patients with intestinal disease. The phylotypes specifically compromised in patients suffering some gut disorders have been identified. Finally, new molecular tools for the detection and quantification of this species and its phylogroups have been designed. Their usefulness to be implemented as complementary molecular tools for the diagnosis and prognosis of intestinal diseases has been determined.
En aquesta tesi doctoral s'ha estudiat la població de Faecalibacterium prausnitzii de pacients amb malalties intestinals i individus sans. En primer lloc, es va realitzar una caracterització fenotípica d'aíllats d'aqueta espècie obtinguts d'individus sans, el que ha permès adquirir coneixement sobre la fisiologia d'aquesta espècie. S'ha evidenciat una possible relació entre la sensibilitat de F.prausnitzii a canvis en les condicions fisicoquímiques de l'intestí i la seva desaparició en un intestí malalt. En segon lloc, s'han realitzat estudis moleculars de les poblacions de F. prausnitzii. Això ha permès definir dos filogrups dins d'aquesta espècie, i descriure la diversitat de filotips en individus sans i pacients amb malalties intestinals.Per primera vegada, s'han identificat els filotips especificament compromesos en pacients que pateixen determinades malalties intestinals. Per últim, s’han dissenyat eines moleculars per a la detecció i quantificació d'aquesta espècie i els seus filogrups. S’ha determinat la utilitat d’aquestes eines moleculars per al suport al diagnòstic o prognòstic de malalties intestinals.
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Johansson, Patrik. "Implications of Local Puumala Hantavirus Genetics and Epidemiology for Diagnostics and Vaccine Development." Doctoral thesis, Umeå : Klinisk mikrobiologi, Umeå universitet, 2005. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-532.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Conrad, K., L. E. C. Andrade, E. K. L. Chan, M. Mahler, P. L. Meroni, G. J. M. Pruijn, G. Steiner, and Y. Shoenfeld. "From autoantibody research to standardized diagnostic assays in the management of human diseases: report of the 12th Dresden Symposium on Autoantibodies." Sage, 2016. https://tud.qucosa.de/id/qucosa%3A35519.

Повний текст джерела
Анотація:
Testing for autoantibodies (AABs) is becoming more and more relevant, not only for diagnosing autoimmune diseases (AIDs) but also for the differentiation of defined AID subtypes with different clinical manifestations, course and prognosis as well as the very early diagnosis for adequate management in the context of personalized medicine. A major challenge to improve diagnostic accuracy is to harmonize or even standardize AAB analyses. This review presents the results of the 12th Dresden Symposium on Autoantibodies that focused on several aspects of improving autoimmune diagnostics. Topics that are addressed include the International Consensus on ANA Patterns (ICAP) and the International Autoantibody Standardization (IAS) initiatives, the optimization of diagnostic algorithms, the description and evaluation of novel disease-specific AABs as well as the development and introduction of novel assays into routine diagnostics. This review also highlights important developments of recent years, most notably the improvement in diagnosing and predicting the course of rheumatoid arthritis, systemic sclerosis, idiopathic inflammatory myopathies, and of autoimmune neurological, gastrointestinal and liver diseases; the potential diagnostic role of anti-DFS70 antibodies and tumor-associated AABs. Furthermore, some hot topics in autoimmunity regarding disease pathogenesis and management are described.
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Книги з теми "Diagnostics of diseases"

1

Lanzer, Peter, and Martin Lipton, eds. Diagnostics of Vascular Diseases. Berlin, Heidelberg: Springer Berlin Heidelberg, 1997. http://dx.doi.org/10.1007/978-3-642-60512-3.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Autoimmune diagnostics. Berlin: De Gruyter, 2011.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

M, Kotlyarov Peter, Mogutov Mikhail S, Alexandrov Yury K, Sencha, A. N. (Aleksandr Nikolaevich), Patrunov Yury N, Belyaev Denis V, and SpringerLink (Online service), eds. Ultrasound Diagnostics of Thyroid Diseases. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Molecular diagnostics of infectious diseases. Berlin: De Gruyter, 2010.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Kharchenko, Vladimir P., Peter M. Kotlyarov, Mikhail S. Mogutov, Yury K. Alexandrov, Alexander N. Sencha, Yury N. Patrunov, and Denis V. Belyaev. Ultrasound Diagnostics of Thyroid Diseases. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-642-12387-0.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Kessler, Harald H., ed. Molecular Diagnostics of Infectious Diseases. Berlin, New York: DE GRUYTER, 2010. http://dx.doi.org/10.1515/9783110214864.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Kessler, Harald H., ed. Molecular Diagnostics of Infectious Diseases. Berlin, Boston: DE GRUYTER, 2014. http://dx.doi.org/10.1515/9783110328127.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Heffner, Steven. Diagnostics for emerging infectious diseases threats. New York: Kalorama Information, 2003.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Noninvasive diagnostics in vascular disease. New York: McGraw-Hill Book Co., 1989.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Joint IABS/WHO Symposium on Diagnostics and Vaccines for Parasitic Diseases (1985). Diagnostics and vaccines for parasitic diseases: Proceedings. Edited by Tiru M, Hennessen W, and Symposium on Diagnostics and Vaccines for Parasitic Diseases (1985). Basel: karger, 1985.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Частини книг з теми "Diagnostics of diseases"

1

Schulze, Ilka, and Volker Wahn. "Primary Immunodeficiency Diseases." In Cellular Diagnostics, 524–39. Basel: KARGER, 2008. http://dx.doi.org/10.1159/000209178.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Ou, Qishui, Hong Mu, Chunlei Zhou, Zhaojing Zheng, and Juan Geng. "Liver Diseases." In Clinical Molecular Diagnostics, 463–92. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-1037-0_33.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Yang, Lu, Huanyu Ju, Yuan Mu, and Chunrong Gu. "Pancreatic Diseases." In Clinical Molecular Diagnostics, 493–509. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-1037-0_34.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Zheng, Zhaojing, Juan Geng, Ye Jiang, Meijuan Zhang, Ruixia Yang, Gaoxia Ge, Huaguo Xu, and Xiaojie Zhang. "Kidney Diseases." In Clinical Molecular Diagnostics, 553–82. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-1037-0_36.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Avery, Robin K., and Belinda Yen-Lieberman. "Viral Diagnostics." In Principles and Practice of Transplant Infectious Diseases, 841–51. New York, NY: Springer New York, 2019. http://dx.doi.org/10.1007/978-1-4939-9034-4_49.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Yuan, Hong, Jingyuan Zhao, Erfu Xie, Lujiang Yi, Zhaojing Zheng, and Juan Geng. "Endocrine and Metabolic Diseases." In Clinical Molecular Diagnostics, 665–716. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-1037-0_40.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Hwu, Wuh-Liang, Yin-Hsiu Chien, Ni-Chung Lee, Shiao-Fang Wang, Shu-Chuan Chiang, and Li-Wen Hsu. "Application of Mass Spectrometry in Newborn Screening: About Both Small Molecular Diseases and Lysosomal Storage Diseases." In Chemical Diagnostics, 177–96. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/128_2012_354.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Nagan, Narasimhan, Christopher J. Klein, D. Brian Dawson, Myra J. Wick, and Stephen N. Thibodeau. "Genetic Basis of Neurologic and Neuromuscular Diseases." In Molecular Diagnostics, 267–80. Totowa, NJ: Humana Press, 2006. http://dx.doi.org/10.1385/1-59259-928-1:267.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Zhang, Xi, Arutha Kulasinghe, Rafid Shahriyar Karim, and Chamindie Punyadeera. "Saliva Diagnostics for Oral Diseases." In Advances in Salivary Diagnostics, 131–56. Berlin, Heidelberg: Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-662-45399-5_7.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Driskell, Jeremy D., and Ralph A. Tripp. "Infectious Diseases, Vibrational Spectroscopic Approaches to Rapid Diagnostics." In Infectious Diseases, 147–69. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4614-5719-0_7.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Тези доповідей конференцій з теми "Diagnostics of diseases"

1

Pilav, Aida, and Anes Jogunčić. "DIAGNOSTICS OF PREVENTABLE DISEASES IN CARDIOLOGY." In International Scientific Symposium “Diagnostics in Cardiology and Grown-Up Congenital Heart Disease (GUCH)”. Academy of Sciences and Arts of Bosnia and Herzegovina, 2021. http://dx.doi.org/10.5644/pi2021.199.03.

Повний текст джерела
Анотація:
Despite many efforts to diagnose and treat preventable cardiovascular diseases (CVD), more specifically to detect known risk factors, these diseases continue to be the leading cause of morbidity and mortality. Bosnia and Herzegovina belongs among the high-risk countries with standardized death rate (SDR) of 385 per 100 000 inhabitants in 2018. Two leading causes of death are acute myocardial infraction, with rate around 90 deaths per 100 000 inhabitants and stroke with the rate around 80 deaths per 100 000 inhabitants in one year. Both incidents are preventable. Digital interventions are necessary for strengthening of the healthcare system. Benefits of eHealth could be seen in transmission of customized health information for different audiences: transmission of health-event alerts to a specified population group; transmission of health information based on health status or demographics; alerts and reminders to clients; transmission of diagnostic results (or of the availability of results) or even notifications and reminders for appointments, medication adherence, or follow-up services. Successful implementation of digital health requires multidisciplinary approaches, from mass dissemination of recommendations through public health education programs directly in the field, to clinical treatments for patients. All this requires the involvement of numerous actors, from the strategic to the operational level of management within the healthcare system in the country.
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Mesihović-Dinarević, Senka. "UPDATE IN DIAGNOSTICS CARDIOLOGY." In International Scientific Symposium “Diagnostics in Cardiology and Grown-Up Congenital Heart Disease (GUCH)”. Academy of Sciences and Arts of Bosnia and Herzegovina, 2021. http://dx.doi.org/10.5644/pi2021.199.02.

Повний текст джерела
Анотація:
Cardiovascular medicine is an area of clinical practice with a continually rapid expansion of knowledge, guidelines, best practices and new technology in adult cardiovascular medicine as well as in paediatric cardiology medicine. Cardiovascular diseases (CVD) are the leading cause of mortality in the world and cause major costs for the health sector and economy. Cardiovascular imaging indices have a significant impact on the prevention, diagnosis, and treatment of cardiac diseases. Advanced imaging technologies have dramatically improved our ability to detect and treat cardiovascular disease at an early stage. Multimodality imaging techniques - echocardiogram, cardiac computerized tomography, magnetic resonance imaging, simulation 3D models, artificial intelligence - are being used more frequently as their utility is better appreciated. Coronavirus disease 2019 (COVID-19) exerts an unprecedented global impact on public health and health care delivery. Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) causing COVID-19 has reached pandemic levels since March 2020. Patients with cardiovascular (CV) risk factors and established CVD represent a vulnerable population when suffering from COVID-19, and have an increased risk of morbidity and mortality. Severe COVID-19 infection is associated with myocardial damage and cardiac arrhythmia. Diagnostic workup during SARS infection revealed electrocardiographic changes, sub-clinical left ventricular (LV) diastolic impairment and troponin elevation. All professionals in cardiovascular medicine, as a part of lifelong learning process, have the continuous imperative in reviewing novelties, with results data from numerous researches in order to treat all patients according to best practices and evidence-based medicine, especially on this journey through corona pandemic.
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Chumachkova, Е. A., S. A. Portenko, E. S. Kazakova, O. V. Kedrova, S. A. Shcherbakova, T. L. Voznyuk, I. I. Krupinskaya, and R. N. Steshenko. "EPIDEMIOLOGICAL FEATURES OF THE COURSE OF COMMUNITY-ACQUIRED PNEUMONIA IN PATIENTS OF THE CITY OF SARATOV AND SARATOV OBLAST." In Molecular Diagnostics and Biosafety. Federal Budget Institute of Science 'Central Research Institute for Epidemiology', 2020. http://dx.doi.org/10.36233/978-5-9900432-9-9-186.

Повний текст джерела
Анотація:
The aim of the study was to identify the epidemiological features of the course of community-acquired pneumonia among patients in the city of Saratov and the Saratov region during the epidemic of a new coronavirus infection. The medical records of 129 patients of various ages with a confirmed diagnosis of community-acquired pneumonia, who were on inpatient and outpatient treatment, were analyzed. The study established the predominance of pneumonia caused by COVID-19, compared to pneumonia caused by other etiological agents, and the pattern of identification of mild, moderate and severe forms of the disease from the moment the first signs of the disease appear. The computed tomography of the chest organs was proved to be the most informative diagnostic method. The severity of the inflammatory process in the lungs was analyzed depending on the age of the patient, gender, and the presence of concomitant chronic diseases.
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Korolevich, Alexander N., N. P. Prigun, A. Y. Khairullina, and M. S. Belsley. "Laser correlation spectroscopy for diagnostics gallstone diseases." In SPIE Proceedings, edited by Valery V. Tuchin. SPIE, 2003. http://dx.doi.org/10.1117/12.518635.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Michtchenko, A., A. V. Budagovsky, and O. N. Budagovskaya. "Optical Diagnostics Fungal and Virus Diseases of Plants." In 2015 12th International Conference on Electrical Engineering, Computing Science and Automatic Control (CCE). IEEE, 2015. http://dx.doi.org/10.1109/iceee.2015.7357968.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Tamelo, A. A., N. M. Naumovitch, and D. B. Vladimirov. "System for radiowave diagnostics of oncological skin diseases." In Telecommunication Technology" (CriMiCo 2008). IEEE, 2008. http://dx.doi.org/10.1109/crmico.2008.4676621.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Sidarenka, A. V., H. A. Bareika, L. N. Valentovich, D. S. Paturemski, V. N. Kuptsou, M. A. Titok, and E. I. Kalamiyets. "Molecular diagnostics of bacterial and fungal plant diseases." In 2nd International Scientific Conference "Plants and Microbes: the Future of Biotechnology". PLAMIC2020 Organizing committee, 2020. http://dx.doi.org/10.28983/plamic2020.229.

Повний текст джерела
Анотація:
Taxon-specific primers were developed and PCR conditions were optimized for diagnostics of bacterial and fungal plant pathogens. Methods for phytopathogens DNA isolation from plant material, soil and water were selected.
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Petrova, Galina P., Yurii M. Petrusevich, Sergei G. Alexeev, and Andrei V. Ivanov. "Laser light scattering in diagnostics of widespread diseases." In International Conference on: Advanced Laser Technologies (ALT'01), edited by Dan C. Dumitras, Maria Dinescu, and Vitali I. Konov. SPIE, 2002. http://dx.doi.org/10.1117/12.478659.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Bryanskaya, Ekaterina, Irina Makovik, A. Bukin, Olga Bibikova, Boris M. Shuraev, Olaf Minet, Ursulla Zabarilo, Andrey Dunaev, and Viacheslav Artyushenko. "Diagnosis of inflammatory diseases of the paranasal sinuses using digital diaphanoscopy." In Preclinical and Clinical Optical Diagnostics, edited by J. Quincy Brown and Ton G. van Leeuwen. SPIE, 2019. http://dx.doi.org/10.1117/12.2526835.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Osyanin, K. A., K. V. Usoltsev, D. A. Mirgazov, and L. I. Zaynullin. "THE MODIFICATION OF DNA ISOLATION METHOD TO INCREASE PCR SENSITIVITY IN LABORATORY DIAGNOSTICS OF INFECTIOUS DISEASES." In Molecular Diagnostics and Biosafety. Federal Budget Institute of Science 'Central Research Institute for Epidemiology', 2020. http://dx.doi.org/10.36233/978-5-9900432-9-9-221.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Звіти організацій з теми "Diagnostics of diseases"

1

Mukundan, Harshini. The Microbe Strikes Back: Emerging infectious Diseases and the need for point of care diagnostics. Office of Scientific and Technical Information (OSTI), November 2018. http://dx.doi.org/10.2172/1481963.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

P, Clarós. The Value of Imaging Diagnostics in the Kimura’s Disease. Science Repository, July 2019. http://dx.doi.org/10.31487/j.rdi.2019.03.03.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Davis, Robert E., Edna Tanne, James P. Prince, and Meir Klein. Yellow Disease of Grapevines: Impact, Pathogen Molecular Detection and Identification, Epidemiology, and Potential for Control. United States Department of Agriculture, September 1994. http://dx.doi.org/10.32747/1994.7568792.bard.

Повний текст джерела
Анотація:
Grapevine yellows diseases characterized by similar symptoms have been reported in several countries including Israel, the United States, France, Italy, Spain, Germany and Australia. These diseases are among the most serious known in grapevine, but precise knowledge of the pathogens' identities and modes of their spread is needed to devise effective control stratgegies. The overall goals of this project were to develop improved molecular diagnostic procedures for detection and identification of the presumed mycoplasmalike organism (MLO) pathogens, now termed phytoplasmas, and to apply these procedures to investigate impact and spread and potential for controlling grapevine yellows diseases. In the course of this research project, increased incidence of grapevine yellows was found in Israel and the United States; the major grapevine yellows phytoplasma in Israel was identified and tis 16S rRNA gene characterized; leafhopper vectors of this grapevine yellows phytoplasma in Israel were identified; a second phytoplasma was discovered in diseased grapevines in Israel; the grapevine yellows disease in the U.S. was found to be distinct from that in Israel; grapevine yellows in Virginia, USA, was found to be caused by two different phytoplasmas; both phytoplasmas in Virginia grapevines were molecularly characterized and classified; commercial grapevines in Europe were discovered to host a phytoplasma associated with aster yellow disease in the USA, but this phytoplasma has not been found in grapevine in the USA; the Australian grapevine yellows phytoplasma was found to be distinct from the grapevine phytoplasmas in Israel, the United States and Europe and was described and named "Candidatus phytoplasma australiense", and weed host plants acting as potential reservoirs of the grapevine phytoplasmas were discovered. These and other findings from the project should aid in the design and development of strategies for managing the grapevine yellows disease problem.
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Sun, Lina, Yanan Han, Hua Wang, Huanyu Liu, Shan Liu, Hongbin Yang, Xiaoxia Ren, and Ying Fang. MicroRNAs as Potential Biomarkers for the Diagnosis of Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, February 2022. http://dx.doi.org/10.37766/inplasy2022.2.0027.

Повний текст джерела
Анотація:
Review question / Objective: The purpose of this systematic review was to systematically review the clinical studies regarding miRNAs as diagnostic biomarkers for inflammatory bowel disease and assess the overall diagnostic accuracy of miRNAs. Condition being studied: The symptoms of inflammatory bowel disease (IBD) are highly variable. The diagnosis of IBD must be made through medical history, physical, laboratory, radiologic, endoscopic, and histological examinations. However, these diagnostic techniques are not specific and sometimes even equivocal. Therefore, reliable biomarkers are urgently needed in the diagnosis of IBD. Several clinical and preclinical researches have shown that dysregulated microRNAs (miRNAs) play a crucial role in IBD development. miRNAs, as single-stranded noncoding RNAs that contain 22-24 nucleotides, can post-transcriptionally regulate gene expression by blocking mRNA translation or degrading target mRNAs. miRNAs are widely involved in physiological and pathological cellular processes, such as differentiation, proliferation and apoptosis. Besides, they are stable, noninvasive, and resistant to degradation by ribonucleases, making them valuable targets in the diagnosis, monitoring, prognosis, and treatment of diseases. To date, inconsistent results have been found about miRNA expression profiling in the patients with IBD. Moreover, the diagnostic accuracy of miRNAs for IBD has not been reported in any meta-analysis.
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Langston, J. W. Validating Diagnostic and Screening Procedures for Pre-Motor Parkinson's Disease. Fort Belvoir, VA: Defense Technical Information Center, April 2012. http://dx.doi.org/10.21236/ada568437.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Langston, J. W., and Samuel M. Goldman. Validating Diagnostic and Screening Procedures for Pre-Motor Parkinson's Disease. Fort Belvoir, VA: Defense Technical Information Center, April 2013. http://dx.doi.org/10.21236/ada602970.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Langston, J. W., and Samuel M. Goldman. Validating Diagnostic and Screening Procedures for Pre-Motor Parkinson's Disease. Fort Belvoir, VA: Defense Technical Information Center, April 2014. http://dx.doi.org/10.21236/ada599235.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Zuckermann, Ronald. Molecular Recognition of Protein Nanofibers as a Basis for Prior Disease Diagnostics. Office of Scientific and Technical Information (OSTI), February 2012. http://dx.doi.org/10.2172/1331981.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Vaidya, A., S. Nasarabadi, and F. Milanovich. Optimization of RNA Purification and Analysis for Automated, Pre-Symptomatic Disease Diagnostics. Office of Scientific and Technical Information (OSTI), June 2005. http://dx.doi.org/10.2172/15016765.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

López-Valverde, Nansi, Antonio López-Valverde, Ana Suarez, Bruno Macedo de Sousa, and Juan Manuel Aragoneses. Association of gastric infection and periodontal disease through Helicobacter pylori as a common denominator: A systematic review and meta-analysi. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, October 2021. http://dx.doi.org/10.37766/inplasy2021.10.0097.

Повний текст джерела
Анотація:
Review question / Objective: Is gastric helicobacter pylori infection related to periodontal diseases? Condition being studied: Therefore, the aim of this systematic review and meta-analysis was to identify and analyze clinical studies to determine the direct correlation between Helicobacter Pylori gastric infection andPeriodontal Disease. Study designs to be included: Clinical studies that provided data on Helicobacter Pylori infection in both the stomach and oral cavity, confirmed by polymerase chain reaction (PCR), rapid urease test (RUT) or enzyme-linked immunosorbent assay (ELISA). Clinical studies that associated PD with Helicobacter Pylori. The diagnosis of PD was confirmed ac-cording to the diagnostic criteria in periodontology.
Стилі APA, Harvard, Vancouver, ISO та ін.
Також вас можуть зацікавити розширені добірки на тему "Diagnostics of diseases" для конкретних типів джерел:
Статті в журналах Дисертації Книги
Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!

До бібліографії